Selective splenic artery embolization for the treatment of thrombocytopenia and hypersplenism in paroxysmal nocturnal hemoglobinuria
|
Mar 2014
|
J Hematol Oncol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine
|
Mar 2014
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Multicenter study evaluating the impact of hypomethylating agents as bridging therapy to hematopoietic stem cell transplantation in myelodysplastic syndromes
|
Mar 2014
|
Int J Hematol
|
myelodysplastic syndromes (MDS)
|
Myelodysplastic syndromes
|
Mar 2014
|
Lancet
|
myelodysplastic syndromes (MDS)
|
Eltrombopag in refractory severe aplastic anemia
|
Mar 2014
|
Blood
|
aplastic anemia
|
Effectiveness and safety of different azacitidine dosage regimens in patients with myelodysplastic syndromes or acute myeloid leukemia
|
Mar 2014
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Toward resolving the unsettled role of iron chelation therapy in myelodysplastic syndromes
|
Mar 2014
|
Expert Rev Anticancer Ther
|
myelodysplastic syndromes (MDS)
|
Fishing for myelodysplastic syndromes finds uncaptured cases by state cancer registries: Need for more resources
|
Mar 2014
|
Cancer
|
myelodysplastic syndromes (MDS)
|
Impaired proliferative potential of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway
|
Mar 2014
|
Stem Cells Dev
|
myelodysplastic syndromes (MDS)
|
YAP1 expression in myelodysplastic syndromes and acute leukemias
|
Mar 2014
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|